Head of Venture Investments @ (July 2021 - August 2025)
Sr Director of Venture Investments @ (October 2017 - June 2021)
Board Member @ (January 2023 - July 2025)
Board Member @ (October 2022 - June 2025)
Board Member @ (January 2022 - June 2025)
Board Member @ (March 2021 - June 2025)
Board Member @ (January 2021 - June 2025)
Board Member @ (November 2019 - June 2025)
Board Member @ (November 2019 - June 2025)
Board Observer @ (March 2023 - May 2025)
Board Observer @ (December 2022 - May 2025)
Board Observer @ (January 2023 - April 2025)
Board Member @ (May 2019 - September 2022)
Board Observer @ (January 2020 - January 2022)
Board Member @ (July 2019 - October 2021)
Head of Business Development @ (December 2015 - October 2017)
Scientific Officer Translational Medicine @ (August 2014 - August 2015)
Cardiovascular Scientist @ (August 2011 - August 2014)
Research Associate @ (June 2008 - September 2010)
Biotechnology @ (January 2003 - May 2008)
Lucio Iannone Education
Università degli Studi di Napoli Federico II
Bachelor's degree (Biotechnology)
2002-2006
Imperial College London
Doctor of Philosophy (Ph.D.) (Medicine)
Lucio Iannone Skills
Cell Biology
ABPI code of practice
Biotechnology
Cell Culture
Genetics
Pharmaceutical Industry
Biochemistry
Real Time
Pharmacokinetics
Lifesciences
Pharmacology
Drug development
Ricerca
Strategia
Scienza
Genetica
Industria farmaceutica
Biochimica
Biotecnologia
Biologia molecolare
Scienze naturali
In vitro
R&D
DCF
Discounted cash flow (DCF)
CRISPR-CAS9
oligonucleotides
Investments
Life Sciences
early stage technologies
Private equity
Life sciences investments
Venture capital
In vivo
CRISPR
gene editing
Bloomberg
translation
Corporate Venture Capital
Coltura cellulare
Negotiation
Corporate Development
Financial Analysis
Artificial Intelligence (AI)
Operations Management
Seed Capital
Licensing
ABPI code of practice
Cell Signaling
Microscopy
Molecular Biology
Western Blotting
Myography
Cancro
Microscopia
Biologia cellulare
Western blot
Vascular
Cardio
Crispr Cas9
Discounted Cash Flow Dcf
GraphPad Prism
Sperimentazioni cliniche
Abpi
Rt Pcr
Code of Practice
Protein Expression
Statistics
ImageJ
Artificial Intelligence Ai
Discounted Cash Flow
Artificial Intelligence
Lucio Iannone Summary
Lucio Iannone, based in Cambridge, MA, US, is currently a Sr Managing Director at T1D Fund. Lucio Iannone brings experience from previous roles at Amana Global Partners, COUR Pharma and Leaps by Bayer. Lucio Iannone holds a 2002 - 2006 Bachelor's degree in Biotechnology @ Università degli Studi di Napoli Federico II. With a robust skill set that includes Cell Biology, ABPI code of practice, Biotechnology, Cell Culture, Genetics and more. Lucio Iannone has 3 emails and 4 mobile phone numbers on RocketReach.
Looking for a different Lucio Iannone?
Find contact details for 700 million professionals.